Page last updated: 2024-10-21

8-hydroxy-2-(di-n-propylamino)tetralin and Insulin Sensitivity

8-hydroxy-2-(di-n-propylamino)tetralin has been researched along with Insulin Sensitivity in 2 studies

8-Hydroxy-2-(di-n-propylamino)tetralin: A serotonin 1A-receptor agonist that is used experimentally to test the effects of serotonin.
8-OH-DPAT : A tetralin substituted at positions 1 and 7 by hydroxy and dipropylamino groups respectively

Research Excerpts

ExcerptRelevanceReference
" Chronic administration of this compound (2."1.30General pharmacology of S 15261, a new concept for treatment of diabetes. ( Berger, S; Boulanger, M; Della Zuana, O; Duhault, J; Lacour, F; Wierzbicki, M, 1998)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Lacour, F2
Berger, S2
Espinal, J1
Duhault, J2
Boulanger, M1
Della Zuana, O1
Wierzbicki, M1

Other Studies

2 other studies available for 8-hydroxy-2-(di-n-propylamino)tetralin and Insulin Sensitivity

ArticleYear
8-OH-DPAT induces a selective increase in protein intake in ageing overweight animals.
    European journal of pharmacology, 1994, Apr-01, Volume: 255, Issue:1-3

    Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Aging; Animals; Diet; Dietary Proteins; Eating; Energy Intak

1994
General pharmacology of S 15261, a new concept for treatment of diabetes.
    Arzneimittel-Forschung, 1998, Volume: 48, Issue:7

    Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Animals; Biogenic Monoamines; Blood Glucose; Blood Pressure;

1998